Navigation Links
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
Date:10/11/2007

ing, which may provide greater mobility and improved sleep. More information about SBS is available on the website, http://www.shortbowel.com and http://www.glucagon.com.

About GATTEX

A potential first-in-class drug, GATTEX is a proprietary analog of naturally occurring human glucagon-like peptide 2 (GLP-2), a peptide secreted primarily in the distal intestine and involved in the regeneration and repair of the intestinal epithelium. A previous Phase 2 proof-of-concept clinical study in patients with SBS showed that daily subcutaneous injections of GATTEX resulted in significant regeneration of the intestinal lining and improved dietary absorption of nutrients and fluids. Once the company has completed its analysis of data from the Phase 3 SBS study, it expects to pursue a pre-NDA meeting with the U.S. Food and Drug Administration to discuss its potential plan for submitting a New Drug Application. NPS is also pursuing development of GATTEX as a possible treatment for chemotherapy-induced gastrointestinal mucositis in cancer patients and necrotizing enterocolitis in preterm infants.

Conference Call Information

A conference call will be held today at 9:00 a.m. EDT. To participate in the call, dial (866) 770-7125 with passcode 66355061. International callers may dial (617) 213-8066 using the same passcode. In addition, live audio of the conference call will be simultaneously broadcast over the Internet and may be accessed on the company's home page, http://www.npsp.com. A conference call replay will be available until October 22, 2007 at (888) 286-8010, or (617) 801-6888 for international callers, with passcode 47718436. The webcast will be available for replay and iPod(R) download for the same period.

Note: Statements made in this press release, which are not historical in nature, consti
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014  Dompe, a leader in R&D for new ... rhNGF (Recombinant Human Nerve Growth Factor) has been designated as ... (FDA). The candidate drug, developed by the ... for the treatment of neurotrophic keratitis, a degenerative corneal disease ... and is currently without a cure. This is the second ...
(Date:7/23/2014)... 2014 Research and Markets ... Medical Kits and Trays - Global Strategic Business ... http://photos.prnewswire.com/prnh/20130307/600769 This ... Kits and Trays in US$ Thousands by the ... Trays, Custom Basin Kits, Custom Ob/Gyn Kits, General ...
(Date:7/23/2014)... 2014  ArmaGen, a privately held biotechnology company ... neurological disorders, announced today that it has entered ... Shire plc to develop AGT-182, an investigational enzyme ... the central nervous system (CNS) and somatic (body-related) ... II, Hunter syndrome is a rare, severe, progressive ...
Breaking Medicine Technology:Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3
(Date:7/23/2014)... 23, 2014 The discounts that some ... products do not include various skin creams or oil ... skin tightening cream discounts inside of its cost saving ... is now available to offer a direct source for ... products available for sale. Although the guide includes pricing, ...
(Date:7/23/2014)... Men and women who are married ... insurance based on national averages. The Quotes Pros company ... to its comprehensive tool this year to help married ... , Providers that are now underwriting plans on a ... one or two clicks. The intelligent platform used to ...
(Date:7/23/2014)... July 23, 2014 The puffiness that ... using non-surgical techniques, according to a new guide published ... serum sold in the U.S. is now available for ... , The complimentary guide that is now published is ... with under eye puffiness. While surgical techniques are available, ...
(Date:7/23/2014)... 2014 Recently, iFitDress.com, a professional company of ... of 2014 vintage party dresses . Aside from that, ... current discount is up to 63% off. , “We are ... These new items are all manufactured by trustworthy and experienced ... until July 30; it is great to provide such a ...
(Date:7/23/2014)... 23, 2014 In preparation for National ... Millennium Treatment Group is providing tips on choosing a ... society ever since man first figured out the process ... has existed since shortly thereafter. Its basis lies in ... then developing a way to combat that problem while ...
Breaking Medicine News(10 mins):Health News:Skin Tightening Cream Discounts Revealed in New Cost Saving Guide at Consumer Portal 2Health News:Cheap Life Insurance Rates for Married Couples Added to Search System at Insurer Portal Online 2Health News:Puffy Eyes Serum Explored in Complimentary Guide Released at Consumer News Website 2Health News:Cheap 2014 Vintage Party Dresses From Professional Supplier iFitDress.com 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3
... embryos or adult mice to behave like stem cells ... in an immediate early publication of the journal Cell. ... stem cells" (iPS) behaved physically and genetically as stem ... used to treat a host of diseases, such as ...
... a ban on Coke and Pepsi by the Kerala Government, the ... forth a proposal to stop the sale// and production of 11 ... ,Top brass in the companies are very unhappy over these moves, ... company which is not in sync with the reports from ...
... has called for moratoriums on consumer advertising which promotes ... that the products// are safe and that they work. ... group has urged the U.S. Food and Drug Administration ... after a drug or device obtains regulatory approval before ...
... found in a study that instead of dieting, which could ... and thereby a desire// to change it, women who accept ... lowest body mass index (BMI). ,The researchers have ... disorders. Tracy Tylka, assistant professor of psychology and one of ...
... is a rare condition that affects children as well ... named anakinra could alleviate// symptoms and bring down the ... in the August 10 issue of the New England ... Research Program of the National Institute of Arthritis and ...
... a sharp rise in polio cases in the country with ... as against a total of 66 last year.// ... upper house, Friday that the transmission of poliovirus may continue ... target". ,In a written answer he said that ...
Cached Medicine News:Health News:Only A Few Differentiating Factors Between Adult And Stem Cells 2Health News:Drug Advertising needs to be Limited 2Health News:Study Finds Healthier Women Are Those Who Accept The Way They Look 2Health News:NOMID Symptoms Helped By Arthritis Drug 2Health News:NOMID Symptoms Helped By Arthritis Drug 3
... Model 3085 temporary pacemaker is designed to ... for temporary atrial or ventricular or A-V ... where such pacing modes are indicated for ... Model 3085 can be used to measure ...
... a unique left ventricular assist device that helps ... being used in a small group of patients ... of an FDA-approved Feasibility Study. The patient can ... power source for minutes or hours. The Kantrowitz ...
... system provides an ideal solution for ... laboratory, satellite lab and the clinic ... method with wedge-smear technology, the ADVIA ... in a safe enclosed environment. The ...
... T600 treadmill has streamlined design, ... a brushless DC motor and ... unique system that operates on ... in smooth operation, remarkably low ...
Medicine Products: